Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 21183 / DOSAGE - CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| didanosine(UNII: K3GDH6OH08) (didanosine - UNII:K3GDH6OH08) | didanosine | 400mg | 250mg | 200mg | 125mg |
Inactive Ingredients
| Ingredient Name | Bristol-Myers Squibb Company |
|---|---|
| CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM(K679OBS311) | |
| diethyl phthalate(UF064M00AF) | |
| GELATIN, UNSPECIFIED(2G86QN327L) | |
| methacrylic acid - methyl methacrylate copolymer (1:2)(5KY68S2577) | |
| sodium hydroxide(55X04QC32I) | |
| sodium starch glycolate type a potato(5856J3G2A2) | |
| talc(7SEV7J4R1U) | |
| titanium dioxide(15FIX9V2JP) |
